CN116396241A - Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid - Google Patents

Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid Download PDF

Info

Publication number
CN116396241A
CN116396241A CN202310384645.9A CN202310384645A CN116396241A CN 116396241 A CN116396241 A CN 116396241A CN 202310384645 A CN202310384645 A CN 202310384645A CN 116396241 A CN116396241 A CN 116396241A
Authority
CN
China
Prior art keywords
reaction
ethyl
oxathiazolidine
butyl
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310384645.9A
Other languages
Chinese (zh)
Inventor
陈建芳
李波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Youfu Pharmaceutical Technology Co ltd
Original Assignee
Nanjing Youfu Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Youfu Pharmaceutical Technology Co ltd filed Critical Nanjing Youfu Pharmaceutical Technology Co ltd
Priority to CN202310384645.9A priority Critical patent/CN116396241A/en
Publication of CN116396241A publication Critical patent/CN116396241A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid, wherein the preparation of the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid takes (R) -2-amino-1-butanol as a starting material, and the (R) -2-amino-1-butanol is subjected to acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction to obtain a finished product. The preparation method of the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid provided by the invention is a brand new preparation method, and has the advantages of safety, environmental protection and easiness in large-scale production.

Description

Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid
Technical Field
The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid.
Background
Tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid as important medical intermediate with CAS number of 1417287-40-1 and molecular formula of C 9 H 17 NO 5 S。
Through searching, the prior preparation methods of the tertiary butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid mainly comprise two methods:
1) The principle of the first preparation method is as follows:
Figure BDA0004173401100000011
Ref:1)Journal of Organic Chemistry,2010,vol.75,#3,p.937-940.
2)Advanced Synthesis and Catalysis,2015,vol.357,#9,p.2132-2142.
the method mainly adopts N-Boc- (R) -2-amino-1-butanol as a starting material. Step one, adopting thionyl chloride/pyridine for acylation reaction, so that the post-treatment is complicated, and the cyclization yield is not ideal; the second step adopts heavy metal catalyst ruthenium trichloride, which is expensive and is unfavorable for mass preparation;
2) The principle of the second preparation method is as follows:
Figure BDA0004173401100000012
Ref:1)CN202010253576.
the method mainly adopts N-Boc- (R) -2-amino-1-butanol as a starting material, and synthesizes a target product by a one-step method. However, the reaction solvent is used in a large amount, and the sulfonyl chloride with higher toxicity and poorer safety is used as an acylating agent, so that the mass preparation is difficult.
Therefore, there is a need to provide a novel, safe, environment-friendly process for preparing tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid which is easy to produce in a large scale.
Disclosure of Invention
The present invention has been made keeping in mind the above problems occurring in the prior art, and an object of the present invention is to provide a process for preparing t-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid.
In order to achieve the technical purpose and the technical effect, the invention is realized by the following technical scheme:
a preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is characterized in that (R) -2-amino-1-butanol is used as a starting material for preparing the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid, and the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is subjected to three steps of reaction, namely, acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction to obtain a finished product.
Further, the reaction in the first step is shown as a formula (I), and an intermediate A is obtained after the reaction:
Figure BDA0004173401100000021
further, the reaction in the first step comprises the following specific steps: sequentially adding dried dichloromethane, triethylamine, (R) -2-amino-1-butanol and 4-dimethylaminopyridine into a reaction kettle, stirring and dissolving, stirring and cooling at-20 ℃ under the nitrogen protection atmosphere, taking dichloromethane to dissolve sulfoxide chloride, dropwise adding into a reaction system, and reacting for a period of time at a constant temperature; TLC monitors that the raw materials are reacted completely, saturated sodium bicarbonate aqueous solution is added for quenching reaction, an organic phase is firstly washed by saturated ammonium chloride aqueous solution and saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, and filtrate is concentrated under reduced pressure to obtain an intermediate A.
Further, the reaction in the second step is shown in a formula (II), and an intermediate B is obtained after the reaction:
Figure BDA0004173401100000031
further, the reaction of the second step comprises the following specific steps: acetonitrile and water are added into a reaction kettle, an intermediate A is added into the reaction kettle, potassium hydrogen persulfate composite salt is added into a reaction system, and the temperature is raised to 80 ℃ and the mixture is stirred for reaction for a period of time; TLC monitors that the raw materials are completely reacted, water is added for separating, an organic phase is washed by saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, the filtrate is decompressed and concentrated to remove the solvent to obtain a crude product, and the crude product is subjected to rapid silica gel column chromatography to obtain an intermediate B.
Further, the reaction in the third step is shown in a formula (III), and a finished product is obtained after the reaction:
Figure BDA0004173401100000032
further, the reaction in the third step comprises the following specific steps: adding the intermediate B into a reaction kettle, adding acetonitrile, triethylamine and 4-dimethylaminopyridine, uniformly stirring, dropwise adding tert-Ding Yangzhi chloroformate at room temperature, and heating to 60 ℃ for reaction for a period of time after adding; TLC monitors the completion of the reaction of the raw materials, cools to room temperature, quench the reaction with saturated aqueous sodium bicarbonate, extract with ethyl acetate, extract the aqueous phase twice with ethyl acetate, combine the organic phases, dry the organic phases with anhydrous magnesium sulfate, filter to remove the desiccant, evaporate the filtrate to dryness, get the finished product of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid.
Further, the finished tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid can be purified by silica gel column chromatography.
The beneficial effects of the invention are as follows:
the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is carried out by taking (R) -2-amino-1-butanol as initial raw material, and carrying out three steps of acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction to obtain the final product; the preparation method is a brand new preparation method and has the advantages of safety, environmental protection and easy scale-up production.
Of course, it is not necessary for any one product to practice the invention to achieve all of the advantages set forth above at the same time.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed for the description of the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and that other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a diagram showing the NMR detection result of the product of the present invention;
FIG. 2 is a second diagram of the NMR detection result of the product of the invention;
FIG. 3 is a schematic diagram of the result of the determination of the optical rotation value of the finished product of the invention;
FIG. 4 is a schematic diagram of LCMS detection results of the finished product of the present invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The concrete terms of the embodiment are as follows:
SM: (R) -2-amino-1-butanol
DMAP: 4-dimethylaminopyridine
TEA: triethylamine
DCM: dichloromethane (dichloromethane)
Oxone: potassium hydrogen persulfate composite salt
Boc-Cl: chloroformate tert-Ding Yangzhi
Boc: boc-group
MeCN: acetonitrile
The specific embodiment of the invention is as follows:
example 1
A preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is characterized in that (R) -2-amino-1-butanol is used as a starting material for preparing the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid, and the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is subjected to three steps of reaction, namely, acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction to obtain a finished product.
The reaction in the first step is shown in a formula (I), and an intermediate A is obtained after the reaction:
Figure BDA0004173401100000051
the reaction in the first step comprises the following specific steps: dried DCM (3.0L), TEA (340.1 g,1.5 eq), SM (200 g,1.0 eq) and DMAP (54.8 g,0.2 eq) are added into a reaction kettle in sequence, stirred and dissolved, stirred and cooled at-20 ℃ under the protection of nitrogen, DCM (1L) is taken to dissolve sulfoxide chloride (280.4 g,1.05 eq), dropwise added into the reaction system, and the reaction is carried out for 4 hours after 1 hour. TLC monitored complete reaction of the starting material, quenched by addition of saturated aqueous sodium bicarbonate (2L), washed once with saturated aqueous ammonium chloride (2L), dried over anhydrous sodium sulfate for 2h, filtered to remove the drying agent, and the filtrate concentrated under reduced pressure to give 273.7g of crude intermediate A oil in 90.2% yield.
Mass spectrometry: MS-ESI:136.0[ M+H ]] +
The reaction in the second step is shown in a formula (II), and an intermediate B is obtained after the reaction:
Figure BDA0004173401100000052
the second step of reaction comprises the following specific steps: acetonitrile (3L) and water (1L) were added to the reaction vessel, intermediate A (273.7 g,1.0 eq) was added to the reaction vessel, oxone (1367.5 g,1.1 eq) was added to the reaction system, and the temperature was raised to 80℃and the reaction was stirred for 4 hours. TLC monitors that the raw materials are completely reacted, water (2L) is added for separating, an organic phase is washed once by saturated sodium chloride aqueous solution (3L), the organic phase is dried by anhydrous sodium sulfate, the filtrate is filtered, the solvent is removed by decompression concentration, crude products are obtained, and the crude products are subjected to rapid silica gel column chromatography, thus obtaining 288.6g of pure intermediate B, and the yield is 94.3%.
Mass spectrometry: MS-ESI:152.0[ M+H ]] +
The reaction in the third step is shown in the formula (III), and a finished product is obtained after the reaction:
Figure BDA0004173401100000062
the reaction in the third step comprises the following specific steps: IM2 (288.6 g,1.0 eq.) was added to the reactor, meCN (4L), TEA (288.0 g,1.5 eq.) and DMAP (46.4 g,0.2 eq.) were added and stirred well, boc-Cl (389.3 g,1.5 eq.) was added dropwise at room temperature, after addition, the reaction was allowed to proceed for 8h at 60 ℃, TLC monitored the starting material was complete, cooled to room temperature, quenched with saturated aqueous sodium bicarbonate solution (4L), extracted with ethyl acetate (4L), the aqueous phase was extracted twice with ethyl acetate (2L), the organic phases were combined, dried over anhydrous magnesium sulfate, filtered, evaporated to dryness, and the crude product obtained was purified by column chromatography to give 432.4g of the final product, yield: 90.5%.
Mass spectrometry: MS-ESI:274.1[ M+Na] +
The results of the product related tests are shown in fig. 1 to 4.
The preferred embodiments of the invention disclosed above are intended only to assist in the explanation of the invention. The preferred embodiments are not exhaustive or to limit the invention to the precise form disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best understand and utilize the invention. The invention is limited only by the claims and the full scope and equivalents thereof.

Claims (8)

1. A process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid, characterised in that: the preparation of the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid takes (R) -2-amino-1-butanol as an initial raw material, and the product is obtained through three steps of reaction, namely acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction.
2. The process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 1, characterised in that the reaction in the first step is as shown in formula (I) to give intermediate a:
Figure FDA0004173401090000011
3. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 2, characterised in that the reaction of the first step comprises the following specific steps: sequentially adding dried dichloromethane, triethylamine, (R) -2-amino-1-butanol and 4-dimethylaminopyridine into a reaction kettle, stirring and dissolving, stirring and cooling at-20 ℃ under the nitrogen protection atmosphere, taking dichloromethane to dissolve sulfoxide chloride, dropwise adding into a reaction system, and reacting for a period of time at a constant temperature; TLC monitors that the raw materials are reacted completely, saturated sodium bicarbonate aqueous solution is added for quenching reaction, an organic phase is firstly washed by saturated ammonium chloride aqueous solution and saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, and filtrate is concentrated under reduced pressure to obtain an intermediate A.
4. A process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 3, characterised in that the reaction in the second step is as shown in formula (II) to give intermediate B after reaction:
Figure FDA0004173401090000012
5. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 4, wherein the reaction in the second step comprises the specific steps of: acetonitrile and water are added into a reaction kettle, an intermediate A is added into the reaction kettle, potassium hydrogen persulfate composite salt is added into a reaction system, and the temperature is raised to 80 ℃ and the mixture is stirred for reaction for a period of time; TLC monitors that the raw materials are completely reacted, water is added for separating, an organic phase is washed by saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, the filtrate is decompressed and concentrated to remove the solvent to obtain a crude product, and the crude product is subjected to rapid silica gel column chromatography to obtain an intermediate B.
6. The process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 5, wherein the reaction in the third step is of formula (III) to give the final product after reaction:
Figure FDA0004173401090000021
7. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 6, wherein the reaction in the third step comprises the following specific steps: adding the intermediate B into a reaction kettle, adding acetonitrile, triethylamine and 4-dimethylaminopyridine, uniformly stirring, dropwise adding tert-Ding Yangzhi chloroformate at room temperature, and heating to 60 ℃ for reaction for a period of time after adding; TLC monitors the completion of the reaction of the raw materials, cools to room temperature, quench the reaction with saturated aqueous sodium bicarbonate, extract with ethyl acetate, extract the aqueous phase twice with ethyl acetate, combine the organic phases, dry the organic phases with anhydrous magnesium sulfate, filter to remove the desiccant, evaporate the filtrate to dryness, get the finished product of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid.
8. The process for producing t-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 7, wherein the finished product of t-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is purified by silica gel column chromatography.
CN202310384645.9A 2023-04-12 2023-04-12 Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid Pending CN116396241A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310384645.9A CN116396241A (en) 2023-04-12 2023-04-12 Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310384645.9A CN116396241A (en) 2023-04-12 2023-04-12 Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid

Publications (1)

Publication Number Publication Date
CN116396241A true CN116396241A (en) 2023-07-07

Family

ID=87007097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310384645.9A Pending CN116396241A (en) 2023-04-12 2023-04-12 Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid

Country Status (1)

Country Link
CN (1) CN116396241A (en)

Similar Documents

Publication Publication Date Title
Van Buu et al. Synthesis of novel chiral imidazolium-based ionic liquids derived from isosorbide and their applications in asymmetric aza Diels–Alder reaction
CN112574163B (en) Method for synthesizing Brazilin natural product (+) -Brazilin
CN110551133A (en) Process for preparing tert-butyl-5- (hydroxymethyl) -7-oxa-2-azaspiro [3.5] nonane-2-carboxylic acid ester
KR20010022595A (en) Process for preparing l-ascorbic acid
CN106366057A (en) Synthetic method of sofosbuvir intermediate
CN116396241A (en) Preparation method of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid
CN116396240A (en) Preparation method of tert-butyl (S) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid
CN112142629B (en) Preparation method of 3-aminosulfonylalanine
CN111269149A (en) Production process of 5- (3,3-dimethylguanidino) -2-oxopentanoic acid
CN103508999A (en) Maxacalcitol synthesizing intermediate and preparation method and application thereof
CN115417803B (en) Synthesis method of Wu Pa tenib intermediate (3R, 4S) -1-benzyloxycarbonyl-4-ethylpyrrolidine-3-carboxylic acid
CN113480453B (en) Synthesis method of NH2-PEG5-NHBoc
CN116496195A (en) Preparation method of (R) -4, 4-difluoro pyrrolidine-2-carboxylic acid
RU2785963C1 (en) Method for producing a condensed tricyclic compound and a corresponding intermediate
CN111004141B (en) New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide
WO2023001088A1 (en) Preparation method of 3- (2, 2, 2-trifluoroethyl) pyrrolidine hydrochloride
CN115784967A (en) Synthesis method of nitroisoindolinone compounds
JPS6024118B2 (en) Process for producing adenosine phosphate derivatives
CN116478076A (en) Preparation method of (2S, 4S) -1-tert-butoxycarbonyl-2- (difluoromethyl) -4-hydroxypyrrolidine
CN116514864A (en) Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid
CN118063328A (en) Efficient low-cost preparation method of 2, 3-dibromo-1-propylamine salt
CN116396201A (en) Preparation method of (2R, 4R) -4-fluoropyrrolidine-2-carboxylic acid
CN115368283A (en) Preparation method of cis-3-fluoro-4-hydroxypyrrolidine with chiral structure or achiral structure and derivatives thereof
CN115710213A (en) Preparation method of cis-chiral 3-fluoro-4-hydroxypiperidine and derivatives thereof
JP6560049B2 (en) Process for producing lenteztrehalose A, compound useful for the process and process for producing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination